Related references
Note: Only part of the references are listed.New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro 1H-NMR Metabonomics
Matthieu Dallons et al.
FRONTIERS IN PHARMACOLOGY (2020)
Effects of steroidal saponins extract from Ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response
Zhongwei Wu et al.
PHARMACEUTICAL BIOLOGY (2019)
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Chien-Hsiang Hsu et al.
CELL (2019)
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
Rohan Samarakoon et al.
BIOMOLECULES (2019)
From trends to transformation: where cardio-oncology is to make a difference
Joerg Herrmann
EUROPEAN HEART JOURNAL (2019)
Sirtuin signaling in cellular senescence and aging
Shin-Hae Lee et al.
BMB REPORTS (2019)
Innovative approaches for cancer treatment: current perspectives and new challenges
Carlotta Pucci et al.
ECANCERMEDICALSCIENCE (2019)
Cardiotoxicity of Anticancer Therapeutics
Jerry Dong et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Polyphenols, autophagy and doxorubicin-induced cardiotoxicity
S. Shabalala et al.
LIFE SCIENCES (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction
Vernon W. Dolinsky
BIOLOGICAL CHEMISTRY (2017)
Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes
Mi-Hua Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
A small molecule inhibitor of PAI-1 protects against Doxorubicin-induced cellular senescence: molecular basis
Asish K. Ghosh et al.
ONCOTARGET (2016)
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes
Paola Altieri et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
Yang Ruan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation
Mehtap Kilic Eren et al.
PLOS ONE (2015)
SASP, a Senescence-Associated Subtilisin Protease, is involved in reproductive development and determination of silique number in Arabidopsis
Dana E. Martinez et al.
JOURNAL OF EXPERIMENTAL BOTANY (2015)
An overview of doxorubicin formulations in cancer therapy
Sangeeta Rivankar
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
PDE4 in the human heart - major player or little helper?
Thomas Eschenhagen
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Redox regulation of SIRT1 in inflammation and cellular senescence
Jae-woong Hwang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning
Ahmed E. Enayetallah et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
Therese Keravis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
Cristina E. Molina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Obesity Induces Signs of Premature Cardiac Aging in Younger Patients The Role of Mitochondria
Bernd Niemann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Attenuation of Endoplasmic Reticulum Stress-Related Myocardial Apoptosis by SERCA2a Gene Delivery in Ischemic Heart Disease
Wei Xin et al.
MOLECULAR MEDICINE (2011)
New therapeutic options in the management of COPD - focus on roflumilast
Sabina Antonela Antoniu
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011)
Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices
Andrea Wohlsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Joao F. Passos et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Armin Hatzelmann et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage
Yasuhiro Maejima et al.
AGING CELL (2008)
PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways
Hyun-Jeong Kwak et al.
CELLULAR SIGNALLING (2008)
Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats
Richard W. Chapman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction
Toshiyuki Takahashi et al.
CIRCULATION (2006)
Proteomics of the heart - Unraveling disease
E McGregor et al.
CIRCULATION RESEARCH (2006)
Myocyte apoptosis in heart failure
VPM van Empel et al.
CARDIOVASCULAR RESEARCH (2005)
Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells
M Mata et al.
THORAX (2005)
Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1)
I Spyridopoulos et al.
BASIC RESEARCH IN CARDIOLOGY (2002)
Share Paper
